A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

INTRODUCTION: Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), approved for treatment of type 2 diabetes mellitus (T2DM). There is limited direct evidence comparing the efficacy and tolerability of exenatide 2 mg once weekly (QW) to other GLP-1 RAs. A network meta-analysis (NMA) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kayaniyil, Sheena, Lozano-Ortega, Greta, Bennett, Heather A., Johnsson, Kristina, Shaunik, Alka, Grandy, Susan, Kartman, Bernt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801811/
https://www.ncbi.nlm.nih.gov/pubmed/26886440
http://dx.doi.org/10.1007/s13300-016-0155-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801811/
https://www.ncbi.nlm.nih.gov/pubmed/26886440
http://dx.doi.org/10.1007/s13300-016-0155-1

Ejemplares similares